16. October 2017

More and more therapeutic proteins are developed for an administration by inhalation to treat respiratory diseases. PEGylation is an interesting approach for sustaining the residence time of these biopharmaceuticals in the lungs and thereby decrease the frequency of administration and the daily burden of inhalation therapies.

18. August 2017

The administration of therapeutic proteins by inhalation is getting more and more important to treat respiratory diseases. To enhance residence time of these biopharmaceuticals in the lungs PEGylation is of interest also to reduce the daily burden of inhalation therapies.